Anika TherapeuticsANIK
About: Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
Employees: 288
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
48% more call options, than puts
Call options by funds: $46K | Put options by funds: $31K
0% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 39
2.95% less ownership
Funds ownership: 88.58% [Q3] → 85.62% (-2.95%) [Q4]
11% less funds holding
Funds holding: 122 [Q3] → 109 (-13) [Q4]
25% less funds holding in top 10
Funds holding in top 10: 4 [Q3] → 3 (-1) [Q4]
36% less capital invested
Capital invested by funds: $324M [Q3] → $206M (-$118M) [Q4]
44% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 27
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Barrington Research Michael Petusky 35% 1-year accuracy 25 / 72 met price target | 33%upside $20 | Outperform Maintained | 13 Mar 2025 |
Financial journalist opinion
Based on 3 articles about ANIK published over the past 30 days









